Somerset Trust Co Has $3.36 Million Position in The Procter & Gamble Company (NYSE:PG)

Somerset Trust Co cut its holdings in The Procter & Gamble Company (NYSE:PG) by 0.7% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 19,392 shares of the company’s stock after selling 139 shares during the quarter. Somerset Trust Co’s holdings in Procter & Gamble were worth $3,359,000 at the end of the most recent quarter.

Other large investors also recently added to or reduced their stakes in the company. Enterprise Bank & Trust Co raised its holdings in shares of Procter & Gamble by 0.7% during the 3rd quarter. Enterprise Bank & Trust Co now owns 10,787 shares of the company’s stock valued at $1,868,000 after purchasing an additional 79 shares in the last quarter. Wedmont Private Capital increased its position in Procter & Gamble by 3.1% during the third quarter. Wedmont Private Capital now owns 36,641 shares of the company’s stock worth $6,124,000 after buying an additional 1,095 shares during the last quarter. Marcum Wealth LLC raised its holdings in Procter & Gamble by 1.2% during the third quarter. Marcum Wealth LLC now owns 13,672 shares of the company’s stock valued at $2,368,000 after buying an additional 158 shares in the last quarter. Abner Herrman & Brock LLC boosted its stake in shares of Procter & Gamble by 3.4% during the 3rd quarter. Abner Herrman & Brock LLC now owns 39,827 shares of the company’s stock worth $6,898,000 after acquiring an additional 1,316 shares in the last quarter. Finally, CWM LLC increased its holdings in shares of Procter & Gamble by 4.2% during the 3rd quarter. CWM LLC now owns 476,257 shares of the company’s stock valued at $82,488,000 after acquiring an additional 19,121 shares during the last quarter. 65.77% of the stock is owned by institutional investors.

Procter & Gamble Trading Up 0.7 %

Shares of PG stock opened at $169.27 on Thursday. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.53 and a current ratio of 0.73. The firm has a fifty day moving average of $171.39 and a 200-day moving average of $166.65. The Procter & Gamble Company has a 52-week low of $141.66 and a 52-week high of $177.94. The stock has a market cap of $399.50 billion, a price-to-earnings ratio of 27.66, a P/E/G ratio of 3.73 and a beta of 0.41.

Procter & Gamble (NYSE:PG) last released its quarterly earnings data on Tuesday, July 30th. The company reported $1.40 earnings per share for the quarter, beating the consensus estimate of $1.37 by $0.03. The company had revenue of $20.53 billion for the quarter, compared to analyst estimates of $20.69 billion. Procter & Gamble had a return on equity of 33.46% and a net margin of 17.71%. The company’s revenue was down .1% compared to the same quarter last year. During the same period in the prior year, the company posted $1.37 EPS. On average, equities research analysts forecast that The Procter & Gamble Company will post 6.97 earnings per share for the current fiscal year.

Procter & Gamble Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be issued a dividend of $1.0065 per share. The ex-dividend date is Friday, October 18th. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.38%. Procter & Gamble’s payout ratio is presently 65.69%.

Analyst Upgrades and Downgrades

PG has been the subject of a number of recent analyst reports. TD Cowen started coverage on Procter & Gamble in a research report on Tuesday, July 23rd. They set a “buy” rating and a $189.00 target price for the company. JPMorgan Chase & Co. raised their target price on shares of Procter & Gamble from $179.00 to $186.00 and gave the company an “overweight” rating in a research note on Thursday, September 19th. Evercore ISI boosted their target price on shares of Procter & Gamble from $177.00 to $183.00 and gave the stock an “outperform” rating in a research report on Thursday, July 18th. DZ Bank raised Procter & Gamble from a “hold” rating to a “buy” rating and set a $190.00 price target on the stock in a research report on Thursday, August 29th. Finally, Barclays cut Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 price objective for the company. in a research report on Monday, September 30th. Ten equities research analysts have rated the stock with a hold rating, twelve have assigned a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat, Procter & Gamble presently has an average rating of “Moderate Buy” and an average price target of $175.05.

Insider Activity

In other news, insider Balaji Purushothaman sold 8,842 shares of the firm’s stock in a transaction that occurred on Thursday, August 1st. The shares were sold at an average price of $164.90, for a total transaction of $1,458,045.80. Following the completion of the sale, the insider now owns 11,537 shares of the company’s stock, valued at approximately $1,902,451.30. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. In other news, CEO R. Alexandra Keith sold 3,373 shares of the company’s stock in a transaction that occurred on Monday, August 5th. The shares were sold at an average price of $170.00, for a total transaction of $573,410.00. Following the transaction, the chief executive officer now directly owns 21,513 shares in the company, valued at approximately $3,657,210. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Balaji Purushothaman sold 8,842 shares of the business’s stock in a transaction that occurred on Thursday, August 1st. The stock was sold at an average price of $164.90, for a total transaction of $1,458,045.80. Following the completion of the transaction, the insider now owns 11,537 shares of the company’s stock, valued at $1,902,451.30. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 383,194 shares of company stock worth $65,140,718. Corporate insiders own 0.17% of the company’s stock.

Procter & Gamble Company Profile

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.